Willingness to pay for treatment with highly active antiretroviral (HAART) drugs: a rural case study in Cameroon
| Autor: | Igbinosum Gladys Ngwa, Kenneth Ngwambokong Muko, Leslie Chigang, Anke Meiburg, Valentine Che Ngwa, Elvis Shu |
|---|---|
| Rok vydání: | 2007 |
| Předmět: |
Adult
Rural Population medicine.medical_specialty Pediatrics Health (social science) Population Program activities HIV Infections Health services Age Distribution Acquired immunodeficiency syndrome (AIDS) Willingness to pay Cost of Illness Sex factors Antiretroviral Therapy Highly Active medicine Immunology and Allergy Humans Cameroon education Poverty Gynecology education.field_of_study Acquired Immunodeficiency Syndrome business.industry Microeconomic Factors Public Health Environmental and Occupational Health Middle Aged medicine.disease Antiretroviral therapy Infectious Diseases business Attitude to Health |
| Zdroj: | SAHARA J : journal of Social Aspects of HIV/AIDS Research Alliance. 1(2) |
| ISSN: | 1729-0376 |
| Popis: | This paper reports on the willingness of HIV/AIDS patients to pay for the most affordable triple therapy combination of antiretrovirals in a local setting in Cameroon. Questionnaires were used to evaluate willingness to pay, and patients who could still afford their medication 6 months after the survey were also investigated, to give an indication of actual ability to pay. In addition, oral interviews were carried out for clarification. In all, 84 patients out of a total of 186 were involved in the study. Results indicated that more men (39%) were willing to pay than women (22%), although more women (56%) were afflicted than men.Willingness to pay was directly dependent on cost with 69%, 22% and 9% of respondents indicating willingness to pay $1, $2 and $3 a day respectively. After 6 months of treatment, 22% of patients were still on therapy. A majority of patients stopped taking the drugs after 6 months due to financial constraints. Apart from cost, stigma, disbelief and side-effects of medication were found to be the main factors militating against willingness to pay. Improved counselling and provision of information, reduced cost of drugs including laboratory tests, and destigmatisation programmes are recommended to improve patients' ability to pay for antiretrovirals. SAHARA-J (2004) 1(2): 107-113 Keywords: HIV/AIDS, treatment, access to antiretrovirals, drug costs, affordability. RESUME Cette communication porte sur une bonne volonte des patients souffrants du VIH/SIDA a payer un prix assez abordable de la therapie triple des anti-retroviraux dans un milieu rural au Cameroun. Des questionnaires ont ete utilises afin d'evaluer cette bonne volonte a payer les medicaments. De plus, les patients qui avaient les moyens d'acheter leurs medicaments 6 mois apres ces epreuves furent interviewes egalement. En plus de cela, les patients ont ete interviewes avec le but d'obtenir des eclaircissements. Parmi les 186 patients, 84 participaient a l'etude. Les resultats de cette etude ont demontre que davantage d'hommes (39%) avaient la bonne volonte de payer des medicaments que des femmes (22%), tandis que les femmes sont plus souffrantes (56%) que les hommes. Cette volonte de payer etait directement liee au cout des medicaments avec 69%, 22% et 9% des interviewes qui veulent bien payer une somme de $1, $2 et $3 par jour respectivement. Au bout d'une periode de 6 mois de traitement, 22% de patients etaient encore en therapie. Une majorite de patients ont arrete le traitement au bout de 6 mois faute de manque d'argent. En dehors du cout, le stigmate, l'incredulite et les effets secondaires des medicaments etaient les facteurs principaux qui etaient contre la volonte de payer. Il est conseille d'ameliorer les services de consultation, de fournir de l'information, de reduire le cout de medicaments ainsi que les essais en laboratoire et l'elaboration des programmes de destigmatisation afin d'ameliorer la capacite de patients a payer pour les anti-retroviraux. SAHARA-J (2004) 1(2): 107-113 Mots cles: le VIH/SIDA, le traitement, l'acces aux anti-retroviraux, le cout de medicaments, avoir des moyens d'acheter. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|